Medicines Distribution Consents




26 APRIL

NEW ZEALAND GAZETTE

1197

Product:
Refresh Contacts
Active Ingredient:
Carmellose sodium 5mg/mL
Dosage Form:
Eye drops, solution
New Zealand Sponsor:
Allergan New Zealand Limited
Manufacturer:
Allergan Pharmaceuticals (Ireland) Limited, Westport, County Mayo, Ireland

Product:
Sensodyne Dual Protection – (Fresh Mint Gel with Fluoride)
Active Ingredients:
Potassium nitrate 5%w/w
Sodium fluoride 0.221%w/w
Triclosan 0.3%w/w
Dosage Form:
Toothpaste
New Zealand Sponsor:
Stafford-Miller (NZ) Limited
Manufacturer:
Stafford-Miller (Ireland) Limited, Dungarvan, Co. Waterford, Eire

Dated this 17th day of April 2002.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go2689

Consent to the Distribution of a New Related Product

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:

Schedule

Product:
Robitussin Honey Cough (Herbal Flavour)
Active Ingredient:
Menthol 5mg
Dosage Form:
Lozenge
New Zealand Sponsor:
Whitehall Consumer Healthcare (NZ) Limited
Manufacturer:
Powers Pharmaceutical Corp, Brockton, Massachusetts, United States of America

Dated this 17th day of April 2002.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go2691

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Endoxan-Asta
Active Ingredient:
Cyclophosphamide (monohydrate) 1,069mg equivalent to 1000mg cyclophosphamide anhydrous
Dosage Form:
Powder for injection
New Zealand Sponsor:
Baxter Healthcare Limited
Manufacturer:
Asta Medica AG, Halle-Kunsebeck, Germany

Product:
Endoxan-Asta
Active Ingredient:
Cyclophosphamide (monohydrate) 2,138mg equivalent to 2000mg cyclophosphamide anhydrous
Dosage Form:
Powder for injection
New Zealand Sponsor:
Baxter Healthcare Limited
Manufacturer:
Asta Medica AG, Halle-Kunsebeck, Germany

Product:
Endoxan-Asta
Active Ingredient:
Cyclophosphamide (monohydrate) 534.5mg equivalent to 500mg cyclophosphamide anhydrous
Dosage Form:
Powder for injection
New Zealand Sponsor:
Baxter Healthcare Limited
Manufacturer:
Asta Medica AG, Halle-Kunsebeck, Germany

Product:
Oxis Turbuhaler
Active Ingredient:
Eformoterol fumarate 12µg/dose
Dosage Form:
Powder for inhalation
New Zealand Sponsor:
AstraZeneca Limited
Manufacturer:
AstraZeneca AB, Sodertalje, Sweden

Product:
Oxis Turbuhaler
Active Ingredient:
Eformoterol fumarate 6µg/dose
Dosage Form:
Powder for inhalation
New Zealand Sponsor:
AstraZeneca Limited
Manufacturer:
AstraZeneca AB, Sodertalje, Sweden



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2002, No 41


Gazette.govt.nz PDF NZ Gazette 2002, No 41





✨ LLM interpretation of page content

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
17 April 2002
Medicines Act 1981, New Medicines, Distribution Consent, Eye drops, Toothpaste
  • G. R. Boyd, Chief Advisor, Safety and Regulation

🏥 Consent to the Distribution of a New Related Product

🏥 Health & Social Welfare
17 April 2002
Medicines Act 1981, New Related Product, Distribution Consent, Lozenge
  • G. R. Boyd, Chief Advisor, Safety and Regulation

🏥 Consent to the Distribution of Changed Medicines

🏥 Health & Social Welfare
17 April 2002
Medicines Act 1981, Changed Medicines, Distribution Consent, Powder for injection, Powder for inhalation
  • G. R. Boyd, Chief Advisor, Safety and Regulation